Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom.

Faldu, Priyansh; Sharma, Kamal; Sharma, Shaival; Ramani, Smeet; Dadhania, Nain; Konat, Ashwati

Faldu, Priyansh; Sharma, Kamal; Sharma, Shaival; Ramani, Smeet; Dadhania, Nain; Konat, Ashwati.

Afiliação

Faldu P; MBBS Intern, B.J. Medical College and Civil Hospital, Ahmedabad, India.
Sharma K; Department of Cardiology, SAL Hospital, Ahmedabad, India.
Sharma S; MBBS Intern, B.J. Medical College and Civil Hospital, Ahmedabad, India.
Ramani S; MBBS Intern, B.J. Medical College and Civil Hospital, Ahmedabad, India.
Dadhania N; MBBS Intern, B.J. Medical College and Civil Hospital, Ahmedabad, India.
Konat A; Department of Zoology, Biomedical Technology and Human Genetics, Gujarat University, Ahmedabad, India.

Front Cardiovasc Med ; 9: 916588, 2022.

Article em En | MEDLINE | ID: mdl-35898270

Palavras-chave

HeartMate II; HeartWare (HVAD); cost-effectiveness; destination therapy (DT); heart failure; left ventricular assist device (LVAD)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google